MIRELLA TORTA
78 works · 2,025 citations · h-index 25
Top works
- INCIDENCE OF SKELETAL COMPLICATIONS IN PATIENTS WITH BONE METASTATIC PROSTATE CANCER AND HORMONE REFRACTORY DISEASE: PREDICTIVE ROLE OF BONE RESORPTION AND FORMATION MARKERS EVALUATED AT BASELINE
- Circulating neuroendocrine markers in patients with prostate carcinoma
- Differential Patterns of Bone Turnover in Relation to Bone Pain and Disease Extent in Bone in Cancer Patients with Skeletal Metastases
- Chromogranin A Expression in Patients With Hormone Naïve Prostate Cancer Predicts the Development of Hormone Refractory Disease
- Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease
- Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease
- Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension
- Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study
- Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease
- Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts
- Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience
- Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
- Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast
- Metabolic Effects of Single-Dose Pamidronate Administration in Prostate Cancer Patients with Bone Metastases
- Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk
- Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
- Pamidronate administration improves the secondary hyperparathyroidism due to “Bone hunger syndrome” in a patient with osteoblastic metastases from prostate cancer
- Serum levels of bone GLA protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegly: Effects of long-term octreotide treatment
- Comparison between Two Methods in the Determination of Circulating Chromogranin A in Neuroendocrine Tumors (NETs): Results of a Prospective Multicenter Observational Study
- The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.